// App-Quantinova.ai

e22101 : Evaluation of proliferation and apoptosis markers in circulating tumor cells (CTCs) of women with early breast cancer who are candidates for tumor dormancy.

Researchers

Presenter

  • Maria Spiliotaki

Principal Investigators

  • Haris Markomanolaki

  • Galatea Kallergi

  • Maria A. Papadaki

  • Vassilis Georgoulias

  • Dimitrios Mavroudis

  • Sofia Agelaki

Medical Centers

  • University General Hospital of Heraklion, Department of Medical Oncology, Heraklion, Greece

  • Laboratory of Tumor Cell Biology, School of Medicine, University of Crete, Heraklion, Greece

Locations

  • Greece

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Peripheral blood mononuclear cell

  • Circulating tumor cells

  • Proliferation marker protein Ki-67

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved